Tapponnier, Maxime

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 6.

Journal Article

Iglesias, Juan F; Roffi, Marco; Losdat, Sylvain; Muller, Olivier; Degrauwe, Sophie; Kurz, David J; Haegeli, Laurent; Weilenmann, Daniel; Kaiser, Christoph; Tapponnier, Maxime; Cook, Stéphane; Cuculi, Florim; Heg, Dik; Windecker, Stephan; Pilgrim, Thomas (2023). Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trial. Lancet, 402(10416), pp. 1979-1990. Elsevier 10.1016/S0140-6736(23)02197-9

Häner, Jonas D; Rohla, Miklos; Losdat, Sylvain; Iglesias, Juan F; Muller, Olivier; Eeckhout, Eric; Kurz, David; Weilenmann, Daniel; Kaiser, Christoph; Tapponnier, Maxime; Roffi, Marco; Heg, Dik; Windecker, Stephan; Pilgrim, Thomas (2023). Ultrathin-Strut versus Thin-Strut Drug-Eluting Stents for Multi- and Single-Stent Lesions: A Lesion-Level Subgroup Analysis of Two Randomized Trials. American Heart Journal, 263, pp. 73-84. Elsevier 10.1016/j.ahj.2023.05.004

Pilgrim, Thomas; Muller, Olivier; Heg, Dik; Roffi, Marco; Kurz, David J; Moarof, Igal; Weilenmann, Daniel; Kaiser, Christoph; Tapponnier, Maxime; Losdat, Sylvain; Eeckhout, Eric; Valgimigli, Marco; Jüni, Peter; Windecker, Stephan; Iglesias, Juan F (2021). Biodegradable- Versus Durable-Polymer Drug-Eluting Stents for STEMI: Final 2-Year Outcomes of the BIOSTEMI Trial. JACC. Cardiovascular Interventions, 14(6), pp. 639-648. Elsevier 10.1016/j.jcin.2020.12.011

Iglesias, Juan F; Muller, Olivier; Heg, Dik; Roffi, Marco; Kurz, David J; Moarof, Igal; Weilenmann, Daniel; Kaiser, Christoph; Tapponnier, Maxime; Stortecky, Stefan; Losdat, Sylvain; Eeckhout, Eric; Valgimigli, Marco; Odutayo, Ayodele; Zwahlen, Marcel; Jüni, Peter; Windecker, Stephan; Pilgrim, Thomas (2019). Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial. Lancet, 394(10205), pp. 1243-1253. Elsevier 10.1016/S0140-6736(19)31877-X

Iglesias, Juan F; Muller, Olivier; Zaugg, Serge; Roffi, Marco; Kurz, David J; Vuilliomenet, André; Weilenmann, Daniel; Kaiser, Christoph; Tapponnier, Maxime; Heg, Dik; Valgimigli, Marco; Eeckhout, Eric; Jüni, Peter; Windecker, Stephan; Pilgrim, Thomas (2018). A comparison of an ultrathin strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for patients with acute stsegment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the BIOSTEMI trial. EuroIntervention, 14(6), pp. 692-699. Europa Digital & Publishing 10.4244/EIJ-D-17-00734

Dataset

Iglesias, Juan F; Muller, Olivier; Heg, Dik; Roffi, Marco; Kurz, David J; Moarof, Igal; Weilenmann, Daniel; Kaiser, Christoph; Tapponnier, Maxime; Stortecky, Stefan; Losdat, Sylvain Pierre; Eeckhout, Eric; Valgimigli, Marco; Odutayo, Ayodele; Zwahlen, Marcel; Jüni, Peter; Windecker, Stephan; Pilgrim, Thomas (2019). Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial [Dataset].

This list was generated on Sat Dec 21 10:34:33 2024 CET.
Provide Feedback